PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

Avoid false market narratives in 2026: why Exxon, Chevron & COP face oil oversupply risk, while AI-driven tech stays bullish.

Jan. 13, 2026 Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the risk of falls and confusion. A new study shows that while ...